PNC Financial Services Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-97
Closed -$7K 4725
2022
Q2
$7K Sell
97
-8,449
-99% -$610K ﹤0.01% 3924
2022
Q1
$230K Buy
8,546
+888
+12% +$23.9K ﹤0.01% 2161
2021
Q4
$364K Sell
7,658
-28
-0.4% -$1.33K ﹤0.01% 1891
2021
Q3
$511K Buy
7,686
+84
+1% +$5.59K ﹤0.01% 1593
2021
Q2
$594K Buy
7,602
+2,482
+48% +$194K ﹤0.01% 1494
2021
Q1
$484K Buy
5,120
+460
+10% +$43.5K ﹤0.01% 1588
2020
Q4
$568K Buy
4,660
+620
+15% +$75.6K ﹤0.01% 1403
2020
Q3
$352K Buy
4,040
+860
+27% +$74.9K ﹤0.01% 1578
2020
Q2
$206K Buy
3,180
+640
+25% +$41.5K ﹤0.01% 1910
2020
Q1
$114K Buy
+2,540
New +$114K ﹤0.01% 2146